Oppenheimer & Co. Inc. Sells 2,852 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

Oppenheimer & Co. Inc. decreased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 27.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,500 shares of the biotechnology company’s stock after selling 2,852 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Axon Enterprise were worth $3,945,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Pinion Investment Advisors LLC increased its stake in Axon Enterprise by 3.0% during the 1st quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company’s stock valued at $341,000 after purchasing an additional 19 shares in the last quarter. Kentucky Retirement Systems raised its holdings in shares of Axon Enterprise by 0.4% in the 1st quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company’s stock worth $2,605,000 after acquiring an additional 19 shares during the last quarter. Beacon Pointe Advisors LLC raised its holdings in shares of Axon Enterprise by 2.6% in the 4th quarter. Beacon Pointe Advisors LLC now owns 864 shares of the biotechnology company’s stock worth $513,000 after acquiring an additional 22 shares during the last quarter. Fielder Capital Group LLC raised its holdings in shares of Axon Enterprise by 2.2% in the 4th quarter. Fielder Capital Group LLC now owns 1,176 shares of the biotechnology company’s stock worth $699,000 after acquiring an additional 25 shares during the last quarter. Finally, Interchange Capital Partners LLC raised its holdings in shares of Axon Enterprise by 1.9% in the 4th quarter. Interchange Capital Partners LLC now owns 1,310 shares of the biotechnology company’s stock worth $779,000 after acquiring an additional 25 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 905 shares of the company’s stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total value of $702,632.95. Following the transaction, the president now owns 268,735 shares of the company’s stock, valued at approximately $208,643,166.65. This represents a 0.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Julie A. Cullivan sold 657 shares of the company’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $700.00, for a total transaction of $459,900.00. Following the completion of the transaction, the director now directly owns 1,735 shares in the company, valued at approximately $1,214,500. The trade was a 27.47% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 44,642 shares of company stock worth $30,500,428. Corporate insiders own 4.40% of the company’s stock.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of analyst reports. Barclays upped their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. Bank of America lifted their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a “buy” rating in a research report on Wednesday, June 4th. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a research report on Wednesday, May 14th. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Finally, Needham & Company LLC lifted their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $699.55.

Axon Enterprise Trading Down 1.2%

NASDAQ:AXON opened at $785.07 on Thursday. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $806.64. The stock has a market capitalization of $61.12 billion, a PE ratio of 189.63, a price-to-earnings-growth ratio of 91.43 and a beta of 1.29. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68. The firm’s 50 day moving average is $704.90 and its 200 day moving average is $628.19.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same period in the previous year, the business earned $1.15 EPS. Axon Enterprise’s revenue was up 31.3% compared to the same quarter last year. Sell-side analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.